Intelligent Bio Solutions Inc. SEC filings INBS
Intelligent Bio Solutions Inc. has 467 filings in SEC EDGAR's recent list, going back to Dec 29, 2017. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 23, 2026 | — |
| D | Filing | Sep 14, 2026 | — |
| EFFECT | Filing | Jan 21, 2026 | — |
| CORRESP | Letter to the SEC | Jan 16, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2026 | — |
| D | Filing | Jan 13, 2026 | — |
| EFFECT | Filing | Sep 10, 2025 | — |
| EFFECT | Filing | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| CORRESP | Letter to the SEC | Sep 5, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2025 | — |
| D | Filing | Aug 11, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2025 | — |
| EFFECT | Filing | Mar 27, 2024 | — |
| CORRESP | Letter to the SEC | Mar 25, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2024 | — |
| D | Filing | Mar 22, 2024 | — |
| EFFECT | Filing | Mar 15, 2024 | — |
| CORRESP | Letter to the SEC | Mar 13, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2024 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 5, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| CORRESP | Letter to the SEC | Jul 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2023 | — |
| EFFECT | Filing | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2023 | — |
| D | Filing | Oct 18, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 30, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2022 | — |
| EFFECT | Filing | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 18, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2022 | — |
| EFFECT | Filing | Mar 31, 2021 | — |
| CORRESP | Letter to the SEC | Mar 29, 2021 | — |
| CORRESP | Letter to the SEC | Mar 9, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 16, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2021 | — |
| EFFECT | Filing | Dec 22, 2020 | — |
| CERT | Filing | Dec 22, 2020 | — |
| 8-A12B | Filing | Dec 22, 2020 | — |
| CORRESP | Letter to the SEC | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Dec 18, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 24, 2020 | — |
| CORRESP | Letter to the SEC | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2020 | — |
| CORRESP | Letter to the SEC | Oct 9, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2020 | — |
| CORRESP | Letter to the SEC | Sep 30, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2019 | — |
| CORRESP | Letter to the SEC | Aug 21, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2019 | — |
| CORRESP | Letter to the SEC | Aug 2, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2019 | — |
| CORRESP | Letter to the SEC | Jul 3, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2019 | — |
| DRS | Filing | May 13, 2019 | — |
| 1-Z | Filing | Apr 1, 2019 | — |
| 1-A-W | Filing | Mar 27, 2019 | — |
| QUALIF | Filing | Nov 27, 2018 | — |
| CORRESP | Letter to the SEC | Nov 23, 2018 | — |
| 1-A/A | Filing | Nov 16, 2018 | — |
| CORRESP | Letter to the SEC | Nov 7, 2018 | — |
| 1-A/A | Filing | Nov 7, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2018 | — |
| 1-A | Filing | Oct 22, 2018 | — |
| CORRESP | Letter to the SEC | Oct 19, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2018 | — |
| DOS/A | Filing | Sep 28, 2018 | — |
| DOSLTR | Filing | Sep 27, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2018 | — |
| DOSLTR | Filing | Sep 11, 2018 | — |
| DOS/A | Filing | Sep 11, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2018 | — |
| DOS/A | Filing | Aug 15, 2018 | — |
| DOSLTR | Filing | Aug 14, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2018 | — |
| DOS/A | Filing | Jun 19, 2018 | — |
| DOSLTR | Filing | Jun 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2018 | — |
| DOS | Filing | Dec 29, 2017 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INBS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725430
- Former names
- GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.